Annual CFI
$180.23 M
+$267.43 M+306.69%
December 31, 2023
Summary
- As of February 8, 2025, ARQT annual cash flow from investing activities is $180.23 million, with the most recent change of +$267.43 million (+306.69%) on December 31, 2023.
- During the last 3 years, ARQT annual CFI has risen by +$362.06 million (+199.12%).
- ARQT annual CFI is now at all-time high.
Performance
ARQT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$84.78 M
+$146.91 M+236.44%
September 30, 2024
Summary
- As of February 8, 2025, ARQT quarterly cash flow from investing activities is $84.78 million, with the most recent change of +$146.91 million (+236.44%) on September 30, 2024.
- Over the past year, ARQT quarterly CFI has increased by +$39.23 million (+86.12%).
- ARQT quarterly CFI is now -21.32% below its all-time high of $107.75 million, reached on March 31, 2023.
Performance
ARQT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$68.24 M
+$39.23 M+36.50%
September 30, 2024
Summary
- As of February 8, 2025, ARQT TTM cash flow from investing activities is -$68.24 million, with the most recent change of +$39.23 million (+36.50%) on September 30, 2024.
- Over the past year, ARQT TTM CFI has dropped by -$352.86 million (-123.98%).
- ARQT TTM CFI is now -123.98% below its all-time high of $284.62 million, reached on September 30, 2023.
Performance
ARQT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ARQT Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +306.7% | +86.1% | -124.0% |
| 3 y3 years | +199.1% | +86.1% | -124.0% |
| 5 y5 years | +1662.9% | +86.1% | -124.0% |
ARQT Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +306.7% | -21.3% | +143.0% | -124.0% | +44.4% |
| 5 y | 5-year | at high | +199.1% | -21.3% | +143.0% | -124.0% | +74.8% |
| alltime | all time | at high | +199.1% | -21.3% | +143.0% | -124.0% | +74.8% |
Arcutis Biotherapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $84.78 M(-236.4%) | -$68.24 M(-36.5%) |
| Jun 2024 | - | -$62.14 M(+116.5%) | -$107.47 M(-345.5%) |
| Mar 2024 | - | -$28.70 M(-53.9%) | $43.78 M(-75.7%) |
| Dec 2023 | $180.23 M(-306.7%) | -$62.19 M(-236.5%) | $180.23 M(-36.7%) |
| Sep 2023 | - | $45.55 M(-48.9%) | $284.62 M(+580.8%) |
| Jun 2023 | - | $89.12 M(-17.3%) | $41.81 M(+695.6%) |
| Mar 2023 | - | $107.75 M(+155.3%) | $5.25 M(-106.0%) |
| Dec 2022 | -$87.20 M(+14.8%) | $42.20 M(-121.4%) | -$87.20 M(-17.7%) |
| Sep 2022 | - | -$197.26 M(-475.3%) | -$105.90 M(-211.7%) |
| Jun 2022 | - | $52.56 M(+243.6%) | $94.83 M(-177.3%) |
| Mar 2022 | - | $15.30 M(-34.9%) | -$122.65 M(+61.5%) |
| Dec 2021 | -$75.95 M | $23.50 M(+577.0%) | -$75.95 M(-56.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $3.47 M(-102.1%) | -$175.34 M(-35.2%) |
| Jun 2021 | - | -$164.92 M(-366.0%) | -$270.53 M(+171.9%) |
| Mar 2021 | - | $62.00 M(-181.7%) | -$99.50 M(-45.3%) |
| Dec 2020 | -$181.82 M(+590.7%) | -$75.89 M(-17.2%) | -$181.82 M(+28.1%) |
| Sep 2020 | - | -$91.71 M(-1602.2%) | -$141.93 M(+387.3%) |
| Jun 2020 | - | $6.11 M(-130.0%) | -$29.12 M(-22.1%) |
| Mar 2020 | - | -$20.33 M(-43.5%) | -$37.38 M(+42.0%) |
| Dec 2019 | -$26.32 M(+128.3%) | -$36.00 M(-270.6%) | -$26.32 M(-372.1%) |
| Sep 2019 | - | $21.10 M(-1080.3%) | $9.67 M(-184.7%) |
| Jun 2019 | - | -$2.15 M(-76.8%) | -$11.42 M(+23.2%) |
| Mar 2019 | - | -$9.27 M | -$9.27 M |
| Dec 2018 | -$11.53 M(<-9900.0%) | - | - |
| Dec 2017 | $0.00 | - | - |
FAQ
- What is Arcutis Biotherapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics annual CFI year-on-year change?
- What is Arcutis Biotherapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics quarterly CFI year-on-year change?
- What is Arcutis Biotherapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics TTM CFI year-on-year change?
What is Arcutis Biotherapeutics annual cash flow from investing activities?
The current annual CFI of ARQT is $180.23 M
What is the all time high annual CFI for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high annual cash flow from investing activities is $180.23 M
What is Arcutis Biotherapeutics annual CFI year-on-year change?
Over the past year, ARQT annual cash flow from investing activities has changed by +$267.43 M (+306.69%)
What is Arcutis Biotherapeutics quarterly cash flow from investing activities?
The current quarterly CFI of ARQT is $84.78 M
What is the all time high quarterly CFI for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high quarterly cash flow from investing activities is $107.75 M
What is Arcutis Biotherapeutics quarterly CFI year-on-year change?
Over the past year, ARQT quarterly cash flow from investing activities has changed by +$39.23 M (+86.12%)
What is Arcutis Biotherapeutics TTM cash flow from investing activities?
The current TTM CFI of ARQT is -$68.24 M
What is the all time high TTM CFI for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high TTM cash flow from investing activities is $284.62 M
What is Arcutis Biotherapeutics TTM CFI year-on-year change?
Over the past year, ARQT TTM cash flow from investing activities has changed by -$352.86 M (-123.98%)